Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
We then move to repair by targeting mitochondrial dysfunction, chronic neuroinflammation, glymphatic stasis, and synaptic loss through multimodal bio-interventionsspecifically advanced Photobiomodulation, ketogenic metabolic switching, electromagnetic field therapies, and targeted peptide supplementation
Follow the link to our online course
Clinical trials used doses as high as 1 mg per day without safety concerns, but 300 mcg is the most commonly referenced dose in peptide medicine literature and in the investigational protocols that have been published since the formal trials concluded
Human evidence is limited to a handful of small studies for BPC-157 and even less for the rest, long-term safety data doesnt exist, and the compounds sit in a regulatory grey zone that may shift through 2026
US$ 20.00
US$ 24.18
US$ 26.89
